What Adaptimmune Therapeutics PLC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Wood Gavin | Chief Financial Officer | Sep 02 | Open-market sale · S | −96,000 | $0.01 | −$950 | 0 |
| Bertrand William C Jr | Chief Operating Officer | Aug 28 | Open-market sale · S | −207,000 | $0.01 | −$2.09K | 986,352 |
| Behbahani Ali | Director | Aug 18 | Open-market sale · S | −14,671,794 | $0.01 | −$176K | 0 |
| Behbahani Ali | Director | Aug 15 | Open-market sale · S | −4,828,206 | $0.01 | −$53.1K | 14,671,794 |
| EcoR1 Capital, Llc | 10% owner | Jul 30 | Open-market sale · S | −27,433,338 | $0.10 | −$2.8M | 100,371,882 |
| EcoR1 Capital, Llc | 10% owner | Jul 29 | Open-market sale · S | −2,687,460 | $0.10 | −$272K | 127,805,220 |
| EcoR1 Capital, Llc | 10% owner | Jul 28 | Open-market sale · S | −33,931,740 | $0.11 | −$3.82M | 130,492,680 |
| Lunger John | Chief Patient Supply Officer | Jan 17 | Sale for tax withholding · S | −5,584 | $0.58 | −$3.24K | 7,510 |
| Bertrand William C Jr | Chief Operating Officer | Jan 17 | Sale for tax withholding · S | −5,584 | $0.58 | −$3.24K | 7,510 |
| Norry Elliot | Chief Medical Officer | Jan 17 | Sale for tax withholding · S | −5,584 | $0.58 | −$3.24K | 7,510 |
| Rawcliffe Adrian | Chief Executive Officer | Jan 17 | Sale for tax withholding · S | −30,601 | $0.58 | −$17.8K | 44,327 |
| Bertrand William C Jr | Chief Operating Officer | Jan 15 | Sale for tax withholding · S | −9,803 | $0.57 | −$5.63K | 13,756 |
| Norry Elliot | Chief Medical Officer | Jan 15 | Sale for tax withholding · S | −9,803 | $0.57 | −$5.63K | 13,756 |
| Lunger John | Chief Patient Supply Officer | Jan 15 | Sale for tax withholding · S | −9,803 | $0.57 | −$5.63K | 13,756 |
| Piccina Cintia | Chief Commercial Officer | Jan 15 | Sale for tax withholding · S | −12,991 | $0.57 | −$7.47K | 18,421 |
| Rawcliffe Adrian | Chief Executive Officer | Jan 15 | Sale for tax withholding · S | −29,096 | $0.57 | −$16.7K | 41,582 |
| Bertrand William C Jr | Chief Operating Officer | Jan 13 | Sale for tax withholding · S | −5,471 | $0.59 | −$3.22K | 7,623 |
| Bertrand William C Jr | Chief Operating Officer | Jan 13 | Sale for tax withholding · S | −4,268 | $0.59 | −$2.51K | 5,845 |
| Norry Elliot | Chief Medical Officer | Jan 13 | Sale for tax withholding · S | −8,124 | $0.59 | −$4.78K | 11,516 |
| Norry Elliot | Chief Medical Officer | Jan 13 | Sale for tax withholding · S | −4,268 | $0.59 | −$2.51K | 5,845 |
Loading...